ArticleJournal of gastroenterology2026
The evolving landscape of chronic pancreatitis in Japan: findings from a nationwide epidemiological survey in 2021.
Article in Journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo reassess the clinico-epidemiological characteristics of chronic pancreatitis (CP) in Japan, we conducted a nationwide epidemiological survey.
methodsA two-stage nationwide survey was performed targeting patients with CP treated at participating hospitals in 2021. The first-stage survey estimated the number of patients, and the second-stage survey collected detailed clinical information.
resultsThe estimated number of patients with definite or probable CP in 2021 was 73,590 (prevalence, 58.6 per 100,000 population), representing a 30% increase from 2016. The estimated number of newly diagnosed patients was 17,490, corresponding to an annual incidence of 13.9 per 100,000 population. Detailed clinical data were available for 4633 patients. The male-to-female ratio was 4.15:1, the mean age in 2021 was 64.4 years, and the mean age at diagnosis was 58.7 years. Alcohol was the leading etiology (69.6%), followed by idiopathic CP (24.3%). Notably, alcohol-related CP accounted for 39.5% of female cases. Diabetes mellitus and pancreatic exocrine insufficiency were present in 45.8% and 36.6% of patients, respectively. Endoscopic treatment was the initial intervention in 92.8% of patients undergoing treatment for pancreatic stones and/or pancreatic duct strictures. Malignancies were identified up to the time of the survey in 18.0% of patients, including pancreatic cancer in 89 patients.
conclusionsThe prevalence of CP in Japan continues to increase. The aging CP population, the increasing proportion of alcohol-related CP among women, and the substantial burden of diabetes, exocrine insufficiency, and malignancy underscore the growing healthcare impact of CP and the need for effective prevention and long-term management strategies.
Indexed as
Identifiers
42726107What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.